Proteome-wide mapping and reverse vaccinology-based B and T cell multi-epitope subunit vaccine designing for immune response reinforcement against<i>Porphyromonas gingivalis</i>

Khan, Sidra; Ali, Syed Shujait; Zaheer, Iqra; Saleem, Shoaib; Ziaullah,; Zaman, Nasib; Iqbal, Arshad; Suleman, Muhammad; Wadood, Abdul; Rehman, Ashfaq Ur; Khan, Asghar; Khan, Abbas; Wei, Dong‐Qing

doi:10.1080/07391102.2020.1819423

Cited by 28 publications

(22 citation statements)

References 64 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent advancements and great strides in bioinformatics have generated diverse insilico approaches for the identification of novel vaccine and drug targets [17]. These in-silico approaches were helpful in developing cost-effective vaccines and drugs while reducing the time span [18].…”

Section: Introductionmentioning

confidence: 99%

“…These in-silico approaches were helpful in developing cost-effective vaccines and drugs while reducing the time span [18]. Diverse in-silico studies were conducted over the last 10 years for the identification of mutations, novel vaccine candidates, and drug targets for controlling various pathogens such as Porphyromonas gingivalis [17], Bartenolla bacilliformis [19], Norovirus [18], Mayaro virus [20], Epstein-Barr virus [21], Mycobacterium tuberculosis [22,23], Staphylococcus aureus [24], SARS-CoV2 [25,26] and Streptococcus pneumonia [27]. Immunoinformatics approaches are the most effective tools for the development of specific, stable, and multiepitope vaccines.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Immunoinformatics and Immunogenetics-Based Design of Immunogenic Peptides Vaccine against the Emerging Tick-Borne Encephalitis Virus (TBEV) and Its Validation through In Silico Cloning and Immune Simulation

et al. 2021

Self Cite

View full text Add to dashboard Cite

Pegivirus, HPgV, earlier known as Gb virus and hepatitis G virus, is an enveloped, positive-stranded RNA and lymphotropic virus classified into the Flaviviridae family. The transmission routes primarily involve blood products, with infections worldwide, leading up to 25% of persistent infections. To date, no effective therapeutic means are available to resolve Pegivirus infections. Effective vaccine therapeutics are the best alternative to manage this disease and any associated potential pandemic. Thus, whole proteome-based mining of immunogenic peptides, i.e., CTL (cytotoxic T lymphocytes), HTL (helper T lymphocytes) and B cell epitopes were mapped to design a vaccine ensemble. Our investigation revealed that 29 different epitopes impart a critical role in immune response induction, which was also validated by exploring its physiochemical properties and experimental feasibility. In silico expression and host immune simulation using an agent-based modeling approach confirmed the induction of both primary and secondary immune factors such as IL, cytokines and antibodies. The current study warrants further lab experiments to demonstrate its efficacy and safety.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Immunoinformatics and Immunogenetics-Based Design of Immunogenic Peptides Vaccine against the Emerging Tick-Borne Encephalitis Virus (TBEV) and Its Validation through In Silico Cloning and Immune Simulation

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…The GC content calculated for the optimized codons was 55.45%. Computational cloning, by using the SnapGene software, was done to check the expression of inserted gene, The optimized codon sequence, of vaccine, obtained by reverse translation, was inserted into pET28a (+) vector plasmid at multiple cloning site (MCS) between XhoI and NdeI restriction sites (Sikarwar et al 2013 ; Hasan et al 2019 ; Khan et al 2020 ). Multiple cloning sites are a feature that allows for the insertion of foreign DNA without disrupting the rest of the plasmid which makes it extremely useful in biotechnology, bioengineering, and molecular genetics (Clark 2005 ).…”

Section: Resultsmentioning

confidence: 99%

Subtractive Proteomics and Immuno-informatics Approaches for Multi-peptide Vaccine Prediction Against Klebsiella oxytoca and Validation Through In Silico Expression

Yousafi

Amin

Bibi

et al. 2021

Int J Pept Res Ther

View full text Add to dashboard Cite

Klebsiella oxytoca is a gram-negative bacterium. It is opportunistic in nature and causes hospital acquired infections. Subtractive proteomics and reverse vaccinology approaches were employed to screen out the best proteins for vaccine designing. Whole proteome of K. oxytoca strain ATCC 8724, consisting of 5483 proteins, was used for designing the vaccine. Total 1670 cytotoxic T lymphocyte (CTL) epitope were predicted through NetCTL while 1270 helper T lymphocyte (HTL) epitopes were predicted through IEDB server. The epitopes were screened for non-toxicity, allergenicity, antigenicity and water solubility. After epitope screening 300 CTL and 250 HTL epitopes were submitted to IFN-γ epitope server to predict their Interferon-γ induction response. The selected IFN-γ positive epitopes were tested for their binding affinity with MHCI-DRB1 by MHCPred. The 15 CTL and 13 HTL epitopes were joined by linkers AAY and GPGPG respectively in vaccine construct. Chain C of Pam3CSK4 (PDB ID; 2Z7X) was linked to the vaccine construct as an adjuvant. A 450aa long vaccine construct was submitted to I-TASSER server for 3D structure prediction. Thirteen Linear B cells were predicted by ABCPred server and 10 sets of discontinues epitopes for 3D vaccine structure were predicted by DiscoTope server. The modeled 3D vaccine construct was docked with human Toll-like receptor 2 (PDB ID: 6NIG) by PatchDock. The docked complexes were refined by FireDock. The selected docked complex showed five hydrogen bonds and one salt bridge. The vaccine sequence was reverse transcribed to get nucleotide sequence for In silico cloning. The reverse transcribed sequence strand was cloned in pET28a(+) expression vector. A clone containing 6586 bp was constructed including the 450 bp of query gene sequence.

show abstract

“…Previous studies suggested the use of a membrane protein for designing vaccines [ 44 , 45 , 46 , 47 , 48 ]. Therefore, in this study membrane proteins such as outer membrane, cell membrane, extracellular, and peripheral membrane proteins were used to develop a subunit peptide immunogenic construct.…”

Section: Methodsmentioning

confidence: 99%

Core-Proteomics-Based Annotation of Antigenic Targets and Reverse-Vaccinology-Assisted Design of Ensemble Immunogen against the Emerging Nosocomial Infection-Causing Bacterium Elizabethkingia meningoseptica

Idrees

Noorani

Altaf

et al. 2021

IJERPH

Self Cite

View full text Add to dashboard Cite

Elizabethkingia meningoseptica is a ubiquitous Gram-negative emerging pathogen that causes hospital-acquired infection in both immunocompromised and immunocompetent patients. It is a multi-drug-resistant bacterium; therefore, an effective subunit immunogenic candidate is of great interest to encounter the pathogenesis of this pathogen. A protein-wide annotation of immunogenic targets was performed to fast-track the vaccine development against this pathogen, and structural-vaccinology-assisted epitopes were predicted. Among the total proteins, only three, A0A1T3FLU2, A0A1T3INK9, and A0A1V3U124, were shortlisted, which are the essential vaccine targets and were subjected to immune epitope mapping. The linkers EAAK, AAY, and GPGPG were used to link CTL, HTL, and B-cell epitopes and an adjuvant was also added at the N-terminal to design a multi-epitope immunogenic construct (MEIC). The computationally predicted physiochemical properties of the ensemble immunogen reported a highly antigenic nature and produced multiple interactions with immune receptors. In addition, the molecular dynamics simulation confirmed stable binding and good dynamic properties. Furthermore, the computationally modeled immune response proposed that the immunogen triggered a strong immune response after several doses at different intervals. Neutralization of the antigen was observed on the 3rd day of injection. Conclusively, the immunogenic construct produces protection against Elizabethkingia meningoseptica; however, further immunological testing is needed to unveil its real efficacy.

show abstract

Proteome-wide mapping and reverse vaccinology-based B and T cell multi-epitope subunit vaccine designing for immune response reinforcement againstPorphyromonas gingivalis

Cited by 28 publications

References 64 publications

Immunoinformatics and Immunogenetics-Based Design of Immunogenic Peptides Vaccine against the Emerging Tick-Borne Encephalitis Virus (TBEV) and Its Validation through In Silico Cloning and Immune Simulation

Immunoinformatics and Immunogenetics-Based Design of Immunogenic Peptides Vaccine against the Emerging Tick-Borne Encephalitis Virus (TBEV) and Its Validation through In Silico Cloning and Immune Simulation

Subtractive Proteomics and Immuno-informatics Approaches for Multi-peptide Vaccine Prediction Against Klebsiella oxytoca and Validation Through In Silico Expression

Core-Proteomics-Based Annotation of Antigenic Targets and Reverse-Vaccinology-Assisted Design of Ensemble Immunogen against the Emerging Nosocomial Infection-Causing Bacterium Elizabethkingia meningoseptica

Contact Info

Product

Resources

About